AbbVie and Bristol-Myers to conduct combination trial of Rova-T plus Opdivo and Opdivo + Yervoy regimen

AbbVie and Bristol-Myers Squibb will jointly conduct a Phase I/II clinical trial of Rova-T (rovalpituuzumab tesirine) in combination with Opdivo (nivolumab) and Opdivo + Yervoy (ipilimumab) regimen to treat relapsed extensive-stage, small-cell lung c …
Source: Drug Development Technology - Category: Pharmaceuticals Source Type: news